Eosinophilic pneumonia epidemiology and demographics

Jump to navigation Jump to search


Pneumonia Main Page

Eosinophilic pneumonia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Eosinophilic pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Eosinophilic pneumonia epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Eosinophilic pneumonia epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Eosinophilic pneumonia epidemiology and demographics

CDC onEosinophilic pneumonia epidemiology and demographics

Eosinophilic pneumonia epidemiology and demographics in the news

Blogs on Eosinophilic pneumonia epidemiology and demographics

Directions to Hospitals Treating Eosinophilic pneumonia

Risk calculators and risk factors for Eosinophilic pneumonia epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The prevalence of idiopathic chronic eosinophilic pneumonia (ICEP) remains unknown. The incidence of chronic eosinophilic pneumonia in an Icelandic registry was 0.23 cases/100,000 population per year between 1990 and 2004. ICEP has been reported to contribute to 0 to 2500 per 100,000 of cases included in different registries of interstitial lung diseases. There is no racial predilection to ICEP. Women are more commonly affected by ICEP than men. ICEP typically affects patients in their 30s or 40s.

Epidemiology and Demographics

Incidence and prevalence

  • The incidence of chronic eosinophilic pneumonia in an Icelandic registry was 0.23 cases/100,000 population per year between 1990 and 2004. In registries of interstitial lung disease in Europe, chronic eosinophilic pneumonia accounted for 0 to 2500 per 100,000 of cases of interstitial lung disease.[1]
  • ICEP has been reported to contribute to 0 to 2500 per 100,000 of cases included in different registries of interstitial lung diseases.
  • One third to one half of the ICEP patients have a history of asthma and less than 10% are active smokers.
  • It has recently been reported that ICEP may be primed by radiation therapy for breast cancer.
  • Two-thirds of patients are smokers, but there is usually no history of asthma.

Age

  • Patients of all age groups may develop ICEP but is extremely rare in childhood. CEP typically affects patients in their 30s or 40s.[2]
  • Young adults with a mean age of approximately 30 years.

Race

  • There is no racial predilection to ICEP.[3]

Sex

  • Women are more commonly affected by ICEP than men. The women to men ratio is approximately 2 to 1.[3]

References

  1. . PMID 17277407. Missing or empty |title= (help)
  2. Marchand E, Reynaud-Gaubert M, Lauque D, Durieu J, Tonnel AB, Cordier JF (1998). "Idiopathic chronic eosinophilic pneumonia. A clinical and follow-up study of 62 cases. The Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P)". Medicine (Baltimore). 77 (5): 299–312. PMID 9772920.
  3. 3.0 3.1 Thomeer MJ, Costabe U, Rizzato G, Poletti V, Demedts M (2001). "Comparison of registries of interstitial lung diseases in three European countries". Eur Respir J Suppl. 32: 114s–118s. PMID 11816817.

Template:WH Template:WS